SWP
CTSO icon

ShoreHaven Wealth Partners’s Cytosorbents Corp CTSO Stock Holding History

ShoreHaven Wealth Partners’s Portfolio CTSO Stock Details CTSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-40
Closed – – 107
2021
Q1 		$0 Hold
40
– – ﹤0.01% 285
2020
Q4 		$1K Buy
+40
New +$335 ﹤0.01% 242

Other funds holding CTSO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SC
Skylands Capital Milwaukee, Wisconsin $814M AUM 32.37% 1-Year Est. Return
AC
Avenir Corporation Alexandria, Virginia $821M AUM 4.23% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.81B AUM 83.9% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $832M AUM 24.89% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

ShoreHaven Wealth Partners's CTSO Position: Q2 2021 in Review

ShoreHaven Wealth Partners sold out of Cytosorbents Corp (CTSO) in Q2 2021, closing a stake of 40 shares.

ShoreHaven Wealth Partners first reported a position in CTSO in Q4 2020 and held it in 2 quarters. The position peaked at $1K in Q4 2020. 102 funds tracked by Wall St. Rank hold CTSO as of Q2 2021.

  • ShoreHaven Wealth Partners reported no remaining Cytosorbents Corp position as of Q2 2021 after selling out during the quarter.
  • ShoreHaven Wealth Partners sold 40 Cytosorbents Corp shares in Q2 2021.
  • ShoreHaven Wealth Partners first reported a position in Cytosorbents Corp in Q4 2020 and held it in 2 quarters.
  • ShoreHaven Wealth Partners's Cytosorbents Corp position peaked at $1K in Q4 2020.
  • 102 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q2 2021.

Based on ShoreHaven Wealth Partners's 13F filing for Q2 2021, filed 16 Aug 2021.